Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England
2021 · British Journal of Cancer · 23 citations
https://doi.org/10.1038/s41416-021-01525-4
A
Andrew Hodson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
442
Citations
10
h-index
10
i10-index
Andrew Hodson is an academic researcher from University of Virginia Health System. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & T-cell and Retrovirus Studies & Viral-associated cancers and disorders. The author has an h-index of 10, co-authored 36 publications.
Papers by this author
worksIbrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study
2023 · Blood Advances · 16 citations
https://doi.org/10.1182/bloodadvances.2023011152
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study
2024 · The Lancet Oncology · 8 citations
https://doi.org/10.1016/s1470-2045(24)00598-9
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial
2025 · The Lancet · 6 citations
https://doi.org/10.1016/s0140-6736(25)01432-1
Case reports: combination therapy with proteasome inhibitor Bortezomib and humanized anti-CD25 Basiliximab for treatment of adult T cell leukaemia lymphoma
2014 · Retrovirology · 3 citations
https://doi.org/10.1186/1742-4690-11-s1-p8
The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma
2014 · Retrovirology · 1 citations
https://doi.org/10.1186/1742-4690-11-s1-p9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat